“A one year (53 weeks) repeat dose toxicity study in juvenile cynomolgus monkeys with a 26-week recovery phase”
✓ VerifiedFDA pharmacology/toxicology review, p. 33Source ↗
Pivotal GLP studies
14- and 53-week IT bolus juvenile monkey; 13-week SC juvenile mouse; single-dose IT adult monkey
“The toxicity and pharmacokinetics (PK) of ISIS 396443 were evaluated following single IT bolus doses (up to 7 mg) in adult monkeys or following repeated IT bolus doses (weekly or every other week) for 14 (0.3, 1, or 3 mg/dose) and 53 (0.3, 1, or 4 mg/dose) weeks in juvenile monkeys.”
✓ VerifiedFDA pharmacology/toxicology review, p. 7Source ↗
“CNS safety was assessed as part of the acute and subchronic toxicity studies in monkeys using IT lumbar bolus injection, the intended route of administration in man.”
✓ VerifiedFDA pharmacology/toxicology review, p. 71Source ↗